24-month shelf life when stored properly
If your protocol calls for a 250 mcg dose, you simply draw 10 units
A high purity value ensures that the observed experimental effects are due to the BPC-157 itself, not contaminants
DoD Funding Can Unlock DoD Customers Winning DoD R&D funding carries strategic value beyond the award itself
Theyre slower, narrower, and less efficient
Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms